Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD

Edited by Miguel De la Rosa

Received 11 January 2010; received in revised form 4 March 2010; accepted 4 March 2010. published online 10 March 2010.

Abstract

Oculopharyngeal muscular dystrophy is caused by small alanine expansions in polyadenylate binding protein nuclear 1 (PABPN1) protein resulting in its intranuclear accumulation in skeletal muscle. 3F5 llama antibody specifically interferes with the PABPN1 aggregation process in vitro and in vivo. To understand the structural basis for its epitope recognition we mapped the binding interface of 3F5 with PABPN1 and provide a structural model of the 3F5-PABPN1 complex. We show that 3F5 complementarity determining regions create a cavity in which PABPN1 α-helix domain resides by involving critical residues previously implicated in the aggregation process. These results may increase our understanding of the PABPN1 aggregation mechanism and the therapeutic potential of 3F5.

Abbreviations: PABPN1, polyadenylate binding protein nuclear 1, OPMD, oculopharyngeal muscular dystrophy, HCAb, heavy chain antibody from camelids, NMR, nuclear magnetic resonance, CD, circular dichroism, PABPN1L, PABPN1 labeled at the N-terminus with HiLytePlus™ 647

Keywords: Antibody fragment, Oculopharyngeal muscular dystrophy, PABPN1, Protein aggregation, Protein NMR spectroscopy

a Leiden University Medical Center, Center for Human and Clinical Genetics, Einthovenweg 20, 2300 RC Leiden, The Netherlands

b Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands

c Department of Molecular and Cellular Biology, University of Utrecht, Padualaan 8, 3584 CG Utrecht, The Netherlands

Corresponding author. Fax: +31 71 526 8285.

PII: S0014-5793(10)00204-8

doi:10.1016/j.febslet.2010.03.010

23 of 34